Translational Andrology and Urology
ISSN 2223-4683 · AME Publishing Company · Hong Kong · active 2012–2026
Metrics
- Best Scimago quartile (2025)
- Q2
- Cites per paper (2y)
- 1.8
- SJR
- 0.505
- h-index
- 64
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 1 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Translational Andrology and Urology is Q2 in 1 of its 2 subject categories and Q3 in the other 1. Its best category quartile is Q2.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Urology | Q2 | #59 of 126 |
| Reproductive Medicine | Q3 | #53 of 101 |
- Cites per document (2 years, Scopus)
- 1.61
- Documents indexed in 2025 (Scopus)
- 371
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Translational Andrology and Urology is Q2 in 1 of its 2 Scimago subject categories (2025 edition; best category Urology: Q2, #59 of 126), with SJR 0.505 (Scimago) and an h-index of 64 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Translational Andrology and Urology a predatory journal?
Our screening does not flag Translational Andrology and Urology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Translational Andrology and Urology indexed in Scopus or Web of Science?
Per our venue index, Translational Andrology and Urology appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Translational Andrology and Urology?
Papers in Translational Andrology and Urology are cited about 1.8 times each within two years of publication, and Scimago places it in Q2, with an h-index of 64. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Translational Andrology and Urology (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Translational Andrology and Urology is Q2 in 1 of its 2 subject categories and Q3 in the other 1. By category: Urology: Q2, #59 of 126; Reproductive Medicine: Q3, #53 of 101. Its best category quartile is Q2. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Translational Andrology and Urology is cited about 1.8 times per paper over two years, with an h-index of 64.
What is the Web of Science (JCR) quartile of Translational Andrology and Urology?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Translational Andrology and Urology. The open equivalent is its best Scimago quartile, Q2 in Urology, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Translational Andrology and Urology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
Compare it with its peers: Ranked Pulmonary and Respiratory Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.